TLR7 and influenza: Previous work has demonstrated the efficacy of using a TLR4 agonist in combination with a lipidated TLR7/8 agonist or a lipidated TLR7/8 agonist alone in protecting against influenza challenge (43, 58) either in a DMSO, liposome, or emulsion formulation.